Advertisement

Vascular Optic Neuropathies

  • Mark J. Kupersmith

Abstract

Knowledge of the vascular supply to the optic nerve, retina, and choroid (see Chap. 1) is essential for the understanding of visual defects that are caused by segmental or focal ischemia of the optic nerve or retina. Recall that the optic nerve and the retina have different blood supplies: the retina is supplied by the branches from the central retinal artery and the optic nerve is supplied principally by the posterior ciliary/circle of Haller-Zinn circulation.

Keywords

Optic Nerve Optic Disc Visual Loss Optic Neuropathy Giant Cell Arteritis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cullen JF. Ischaemic optic neuropathy. Trans Ophthalmol Soc UK. 87: 759–774, 1967PubMedGoogle Scholar
  2. 2.
    Kurz O. Vascular opticopathy. Doc Ophthalmol 26: 582–591, 1969PubMedGoogle Scholar
  3. 3.
    Guyer DR, Miller NR, Auer CL, Fine SL. The risk of cerebrovascular disease in patients with anterior ischemic optic neuropathy. Arch Ophthalmol 103: 1136–1142, 1985PubMedGoogle Scholar
  4. 4.
    Gowers WR. A Manual and Atlas of Medical Ophthalmology. London, J and A Churchill, 1882, pp 203–208Google Scholar
  5. 5.
    Uhthoff W. Zu den entzündlichen Sehnervenaffektionen bei Arteriosklerose (Atherosklerose). Ber Zusammenkunft Ophthalmol Dtsch Ges 44: 196–208, 1924Google Scholar
  6. 6.
    Hollenhorst RW, Wagener RW. Loss of vision after distant hemorrhage. Am J Med Sci 218: 209–218, 1950Google Scholar
  7. 7.
    Kurz O. Über Papillitis arteriosclerotica. Ophthalmologica 116: 281–285, 1948PubMedGoogle Scholar
  8. 8.
    Miller GR, Smith JL. Ischemic optic neuropathy. Am J Ophthalmol 62: 103–115, 1966PubMedGoogle Scholar
  9. 9.
    Boghen DR, Glaser JS. Ischemic optic neuropathy, the clinical profile and natural history. Brain 98: 689–708, 1975PubMedGoogle Scholar
  10. 10.
    Hayreh SS. Anterior ischemic optic neuropathy. Arch Ophthalmol 99: 1030–1040, 1981PubMedGoogle Scholar
  11. 11.
    Francois J, Verriest G, Neetens A, et al. Pseudopapillites vasculaire. Bull Soc Ophthalmol Fr 69: 36–57, 1956Google Scholar
  12. 12.
    Hollenhorst RW, Brown JR, Wagener HP, Schick RM. Neurologic aspects of temporal arteritis. Neurology 10: 490–498, 1960PubMedGoogle Scholar
  13. 13.
    Repka MX, Savino PJ, Schatz NJ, Sergott RC. Clinical profile and long-term implications of anterior ischemic optic neuropathy. AJO 96: 478–483, 1983Google Scholar
  14. 14.
    Ellenberger C Jr, Keltner JL, Burde RM. Acute optic neuropathy in older patients. Arch Neurol 28: 182–185, 1973PubMedGoogle Scholar
  15. 15.
    Hayreh SS, Podhajsky P. Visual field defects in anterior ischemic optic neuropathy. Doc Ophthalmol 19: 53–71, 1979Google Scholar
  16. 16.
    Bürde RM. Ischemic optic neuropathies. In: Symposium on neuro-ophthalmology. Trans New Orleans Acad Ophthalmol, Burde RM, Glaser JS, Hollenhorst RW, et al (eds). CV Mosby, St Louis, 1976, pp 25–37Google Scholar
  17. 17.
    Stys PK, Ranson BR, Waxman SG, Davis PK. Proc Natl Acad Sci 87: 4212–4216, 1990PubMedGoogle Scholar
  18. 18.
    Quigley H, Anderson DR. Cupping of the optic in ischemic optic neuropathy. Trans Am Acad Ophthalmol Otolaryngol 83: 755–762, 1977Google Scholar
  19. 19.
    Eagling FM, Sanders MD, Miller SJH. Ischaemic papillopathy. Clinical and fluorescein angiographic review of forty cases. Br J Ophthalmol 58: 990–1008, 1974PubMedGoogle Scholar
  20. 20.
    Miller S. The enigma of glaucoma simplex. Trans Ophthalmol Soc UK 92: 563–581, 1972Google Scholar
  21. 21.
    Lavin PJM, Ellenberger C. Recurrent ischemic optic neuropathy. Neuro-ophthalmology 3: 193–198, 1983Google Scholar
  22. 22.
    Kollarits CR, McCarthy RW, Corrie WS, Swann ER. Norepinephrine therapy of ischemic optic neuropathy. J Clin Neuro-ophthalmol I: 283–288, 1981Google Scholar
  23. 23.
    Borchert M, Lessell S. Progressive and recurrent nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 106: 443–449, 1988PubMedGoogle Scholar
  24. 24.
    Smith JL, Goldhammer. Hypertensive optic neuropathy. Trans Am Acad Ophthalmol Otolaryngol 79: 520–523, 1975Google Scholar
  25. 25.
    Beck RW, Savino PJ, Repka MX, Schatz NJ, Sergott RC. Optic disc structure in anterior ischemic optic neuropathy. Ophthalmology 91: 1334–1337, 1984PubMedGoogle Scholar
  26. 26.
    Kline LB. Progression of visual defects in ischemic optic neuropathy. Am J Ophthalmol 106: 199–203, 1988PubMedGoogle Scholar
  27. 27.
    Foulds WS. Visual disturbances in systemic disorders, optic neuropathy and systemic disease. Trans Ophthalmol Soc UK 89: 125–146, 1969Google Scholar
  28. 28.
    Beck RW, Gamel JW, Willcourt RJ, Berman G. Acute ischemic optic neuropathy in severe preeclampsia. Am J Ophthalmol 90: 342–346, 1980PubMedGoogle Scholar
  29. 29.
    Feit RH, Tomsak RL, Ellenberger C. Structure factors in the pathogenesis of ischemic optic neuropathy. Am J Ophthalmol 98: 105–108, 1984PubMedGoogle Scholar
  30. 30.
    Doro S, Lessell S. Cup-disc ratio and ischemic optic neuropathy. Arch Ophthalmol 103: 1143–1144, 1985PubMedGoogle Scholar
  31. 31.
    Reese AB, Carroll FD. Optic neuritis following cataract extraction. Am J Ophthalmol 45: 659–662, 1958PubMedGoogle Scholar
  32. 32.
    Carroll FD. Optic nerve complications of cataract extraction. Trans Am Acad Ophthalmol Otolaryngol 77: 623–629, 1973Google Scholar
  33. 33.
    Hayreh SS. Anterior ischemic optic neuropathy: IV. Occurrence after cataract extraction. Arch Ophthalmol 98: 1410–1416, 1980PubMedGoogle Scholar
  34. 34.
    Gass JDM, Norton EWD. Cystoid macular edema and papilledema following cataract extraction: a fluorescein funduscopic and angiographic study. Arch Ophthalmol 76: 646–661, 1966PubMedGoogle Scholar
  35. 35.
    Lieberman MF, Shahi A, Green WR. Embolie ischemic optic neuropathy. Am J Ophthalmol 86: 206–210, 1978PubMedGoogle Scholar
  36. 36.
    Burde RM, Smith ME, Black JT. Retinal artery occlusion in the absence of a cherry red spot. Surv Ophthalmol 27: 181–186, 1982PubMedGoogle Scholar
  37. 37.
    Tomsak RL. Ischemic optic neuropathy associated with retinal embolism. AJO 99: 590–592, 1985Google Scholar
  38. 38.
    Portnoy SL, Beer PM, Packer AJ, Van Dyk HJL. Embolie anterior ischemic optic neuropathy. J Clin Neuro-ophthalmol 9: 21–25, 1989Google Scholar
  39. 39.
    Knox DL, Duke JR. Slowly progressive ischemic optic neuropathy. Trans Am Acad Ophthalmol Otolaryngol 75: 1065–1068, 1971PubMedGoogle Scholar
  40. 40.
    Waybright EA, Selhorst JB, Combs J. Anterior ischemic optic neuropathy with internal carotid artery occlusion. Am J Ophthalmol 93: 42–47, 1982PubMedGoogle Scholar
  41. 41.
    Brown GC. Anterior ischemic optic neuropathy occurring in association with carotid artery obstruction. J Clin Neuro-ophthalmol 6: 39–42, 1986Google Scholar
  42. 42.
    Francosis J, Verriest G, Neetens A, et al. Pseudopapillites vasculaire. Ann Oculist 195: 83–885, 1962Google Scholar
  43. 43.
    Cogan DG. Neurology of the Visual System. Charles C. Thomas, Springfield, Illinois, 1966, p 186Google Scholar
  44. 44.
    Quigley HA, Miller NR, Green WR. The pattern of optic nerve fiber loss in anterior ischemic optic neuropathy. Am J Ophthalmol 100: 769–776, 1985PubMedGoogle Scholar
  45. 45a.
    Hayreh SS. Anterior ischaemic optic neuropathy I. Fundus on ophthalmoscopy and fluorescein angiography. Br J Ophthal 58: 955–963, 1974Google Scholar
  46. 45b.
    Hayreh SS. Anterior ischaemic optic neuropathy II. Fundus on ophthalmoscopy and fluorescein angiography. Br J Ophth 58: 964–980, 1974Google Scholar
  47. 45c.
    Hayreh SS. Anterior ischaemic optic neuropathy III. Fundus on ophthalmoscopy and fluorescein angiography. Br J Ophth 58: 981–989, 1974Google Scholar
  48. 46.
    Hayreh SS. Pathogenesis of visual field defects. Br J Ophthalmol 54: 289–311, 1970PubMedGoogle Scholar
  49. 47.
    Hayreh SS. Inter-individual variation in blood supply of the optic nerve head. Its importance in various ischemic disorders of the optic nerve head, and glaucoma, low-tension glaucoma and allied disorders. Doc Ophthalmol 59: 217–246, 1985PubMedGoogle Scholar
  50. 48.
    Fry CL, Carter JE, Kanter MC, Tegeler CH. Is there value in evaluating carotid artery patency in patients with anterior ischemic optic neuropathy. North American Neuro-ophthalmology Society, February 24-28, 1991, UtahGoogle Scholar
  51. 49.
    Ellenberger C. Ischemic optic neuropathy as a possible early complication of vascular hypertension. AJO 88: 1045–1051, 1979Google Scholar
  52. 50.
    Keltner JL, Stamper RL, Becker B. Diphenylhydantoin in ischemic optic neuritis. Trans Am Ophthalmol Soc 70: 113–130, 1973Google Scholar
  53. 51.
    Hayreh SS. Anterior ischemic optic neuropathy. Arch Neurol 38: 675–678, 1981PubMedGoogle Scholar
  54. 52.
    Sergott RC, Cohen MS, Bosley TM, Savino PJ. Optic nerve decompression may improve the progres sive form of nonarteritic ischemic optic neuropathy. Arch Ophthalmol 107: 1743–1754, 1989PubMedGoogle Scholar
  55. 53.
    Hamilton CR Jr, Shelley WM, Tumulty PA. Giant cell arteritis: including temporal arteritis and polymyalgia rheumatica. Medicine 50: 1–27, 1971PubMedGoogle Scholar
  56. 54.
    Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR. Temporal arteritis: a 25 year epidemiologic, clinical and pathologic study. Ann Int Med 188: 162–167, 1978Google Scholar
  57. 55.
    Hauser WA, Ferguson RH, Holley KE, Kurland LT. Temporal arteritis in Rochester, Minnesota, 1951 to 1967. Mayo Clin Proc 46: 597–692, 1971PubMedGoogle Scholar
  58. 56.
    Biller J, Asconape J, Weinblatt ME, Toole JF. Temporal arteritis associated with normal sedimentation rate. JAMA 247: 486–487, 1982PubMedGoogle Scholar
  59. 57.
    Bethlenfalvay NC, Nusynowitz ML. Temporal arteritis. A rarity in the young adults. Arch Int Med 114: 487–489, 1964Google Scholar
  60. 58.
    Stanford RG, Berney SN. Polymyalgia rheumatica and temporal arteritis in blacks: clinical features and HLA typing. J Rheum 4: 435–442, 1977Google Scholar
  61. 59.
    Bielroy L, Ogunkoya A, Frohman LP. Temporal arteritis in blacks. Am J Med 86: 707–708, 1989Google Scholar
  62. 60.
    Jennings GH. Arteritis of temporal arteries. Lancet 234: 424–428, 1938Google Scholar
  63. 61.
    Ali Ibn Isa. Memorandum book of a 10th century oculist (translated by CA Woods). Chicago, Northwestern University Press, 1936Google Scholar
  64. 62.
    Hutchinson J. Diseases of the arteries. On a peculiar form of thrombotic arteritis of the aged which is sometimes productive of gangrene. Arch Surg 1: 323–329, 1890Google Scholar
  65. 63.
    Grahm E, Holland A, Avery A, Russell RWR. Prognosis in giant cell arteritis. Br Med J 282: 269–271, 1981Google Scholar
  66. 64.
    Jonasson F, Cullen JF, Elton RA. Temporal arteritis. A 14 year epidemiological, clinical and prognostic study. Scott Med J 24: 111–118, 1979PubMedGoogle Scholar
  67. 65.
    Hollenhorst RW. Effects of posture on retinal ischemia from temporal arteritis. Arch Ophthalmol 78: 569–577, 1967PubMedGoogle Scholar
  68. 66.
    Nykes WN, Adams GGW, Cullen JF. Temporal arteritis: visual loss associated with posture. Neuroophthalmology 4: 107–109, 1984Google Scholar
  69. 67.
    Raymond LA, Sacks JG, Choromkos E, Khodad G. Short posterior ciliary artery insufficiency with hyperthermia (Uhtoff’s symptom). AJO 90: 619–623, 1980Google Scholar
  70. 68.
    Goldstein JE, Cogan DG. Exercise and the optic nerve of multiple sclerosis. Arch Ophthalmol 72: 168–170, 1964PubMedGoogle Scholar
  71. 69.
    Lipton RB, Solomon S, Wertenbaker C. Gradual loss and recovery of vision in temporal arteritis. Arch Int Med 145: 2252–2253, 1985Google Scholar
  72. 70.
    Symonds C, MacKenzie I. Bilateral loss of vision from cerebral infarction. Brain 80: 415–455, 1957PubMedGoogle Scholar
  73. 71.
    Wilkinson IMS, Russell R, Ross W. Arteries of the head and neck in giant cell arteritis. A pathological study to show the pattern of arterial involvement. Arch Neurol 27: 378–391, 1972PubMedGoogle Scholar
  74. 72.
    Gibb WRG, Urry PA, Lees AJ. Giant cell arteritis with spinal cord infarction and basilar artery thrombosis. J Neurol Neurosurg Psych 48: 945–948, 1985Google Scholar
  75. 73.
    Paulley JW, Hughes JP. Giant-cell arteritis, or arteritis of the aged. Br J Med 2: 1562–1567, 1960Google Scholar
  76. 74.
    Hunder GG, Disney TF, Ward LE. Polymyalgia rheumatica. Mayo Clin Proc 44: 849–879, 1969PubMedGoogle Scholar
  77. 75.
    Fauchald P, Rygvold O, Oystese B. Temporal arteritis and polymyalgia rheumatica. Ann Intern Med 77: 845–852, 1972PubMedGoogle Scholar
  78. 76.
    Ettlinger RE, Hunder GG, Ward LE. Polymalgia rheumatica and giant cell arteritis. Annu Rev Med 29: 15–22, 1978PubMedGoogle Scholar
  79. 77.
    Healey LA, Wilske KR. Polymyalgia rheumatica and giant cell arteritis. West J Med 141: 64–67, 1984PubMedGoogle Scholar
  80. 78.
    Fessel WJ, Pearson CM. Polymyalgia rheumatic and blindness. N Engl J Med 276: 1403–1405, 1967PubMedGoogle Scholar
  81. 79.
    Spiera H, Davison S. Vision loss in cranial arteritis: relation to corticosteroid therapy. Mt Sinai J Med 49: 55–58, 1982PubMedGoogle Scholar
  82. 80.
    Speira H, Davison S. Long-term follow-up of polymyalgia rheumatica. Mt Sinai J Med 45: 225–229, 1978Google Scholar
  83. 81.
    Meadows SP. Temporal or giant-cell arteritis. Proc Roy Soc Med 59: 329–333, 1966PubMedGoogle Scholar
  84. 82.
    Strachman RW, How J, Bewsher PD. Masked giantcell arteritis. Lancet 1: 194–196, 1980Google Scholar
  85. 83.
    Simmons RG, Cogan DG. Occult temporal arteritis. Arch Ophthalmol 68: 8–18, 1962PubMedGoogle Scholar
  86. 84.
    Kansu T, Corbett JJ, Savino P, Schatz NJ. Giant cell arteritis with normal sedimentation rate. Arch Neurol 34: 624–625, 1977PubMedGoogle Scholar
  87. 85.
    Caselli RJ. Giant-cell (temporal) arteritis: a treatable cause of multi-infarct dementia. Neurology 40: 753–755, 1990PubMedGoogle Scholar
  88. 86.
    Monteiro MLR, Coppeto JR, Greco P. Giant cell arteritis of the posterior cerebral circulation presenting with ataxia and ophthalmolplegia. Arch Ophthalmol 102: 407–409, 1984PubMedGoogle Scholar
  89. 87.
    Enzmann D, Scott WR. Intracranial involvement of giant-cell arteritis. Neurology 27: 794–797Google Scholar
  90. 88.
    Paulley JW. Coronary ischaemia and occlusion in giant cell (temporal) arteritis. Acta Med Scand 208: 257–263, 1980PubMedGoogle Scholar
  91. 89.
    Greene GM, Lain D, Sherwin RM, Wilson JE, McManus BM. Giant cell arteritis of the legs: clinical isolation of severe disease with gangrene and amputations. Am J Med 81: 727–733, 1986PubMedGoogle Scholar
  92. 90.
    Ghose MK, Shensa S, Lerner PI. Arteritis of the aged (giant cell arteritis) and fever of unexplained origin. Am J Med 60: 429–436, 1976PubMedGoogle Scholar
  93. 91.
    Bevan AT, Dunnill MS, Harrison MJK. Clinical and biopsy findings in temporal arteritis. Ann Rheum Dis 27: 271–277, 1968PubMedGoogle Scholar
  94. 92.
    Stofferman RA. Lingual infarction in cranial arteritis. JAMA 243: 2422–2423, 1980Google Scholar
  95. 93.
    Wagener HP, Hollenhorst RW. Ocular lesions of temporal arteritis. Am J Ophthalmol 45: 617–630, 1958PubMedGoogle Scholar
  96. 94.
    Walsh FB, Hoyt WF. Clinical Neuro-Ophthalmology, Vol 2, 3rd edn. Baltimore, Williams & Wilkins 1969, pp 1878–1881Google Scholar
  97. 95.
    Sebag J, Thomas JV, Epstein DL, Grant WM. Optic disc cupping in arteritic anterior ischemic optic neuropathy resembles glaucomatious cupping. Ophthalmology 93: 357–361, 1986PubMedGoogle Scholar
  98. 96.
    Henkind P, Charles NC, Pearson J. Histopathology of ischemic optic neuropathy. Am J Ophthalmol 69: 78–90, 1970PubMedGoogle Scholar
  99. 97.
    Tang RA, Kaldis LC. Retinopathy in temporal arteritis. Ann Ophthalmol 14: 652–654, 1982PubMedGoogle Scholar
  100. 98.
    Barricks ME, Traviesa DB, Glaser JS, Levy IS. Ophthalmolplegia in cranial arteritis. Brain 100: 209–221, 1977PubMedGoogle Scholar
  101. 99.
    Sibony PA, Lessell S. Transient oculomotor synkinesis in temporal arteritis. Arch Neurol 41: 87–88, 1984PubMedGoogle Scholar
  102. 100.
    Thomson GTD, Johnston JL, Sharpe JA, Inman RD. Internuclear ophthalmoplegia in giant cell arteritis. J Rheumatol 16: 693–695, 1989PubMedGoogle Scholar
  103. 101.
    Dimant J, Grob D, Brunner NG. Ophthalmoplegia, ptosis, and miosis in temporal arteritis. Neurology 30: 1054–1058, 1980PubMedGoogle Scholar
  104. 102.
    Currie J, Lessell S. Tonic pupils with giant cell arteritis. Br J Ophthalmol 68: 135–138, 1984PubMedGoogle Scholar
  105. 103.
    Davis RH, Daroff RB, Hoyt WF. Tonic pupil after temporal arteritis. Lancet I: 822, 1968Google Scholar
  106. 104.
    Wong RL, Korn JH. Temporal arteritis without an elevated erythrocyte sedimentation rate. Am J Med 80: 959–963, 1986PubMedGoogle Scholar
  107. 105.
    Keltner JL. Giant-cell arteritis. Ophthalmology 89: 1101–1110, 1982PubMedGoogle Scholar
  108. 106.
    Bull BS, Brecher G. An evaluation of the relative merits of the Wintrobe and Westergreen sedimentation methods, including hematocrit correction. AJCP 62: 502–510, 1974PubMedGoogle Scholar
  109. 107.
    Jacobson DM, Slamovits TL. Erythrocyte sedimentation rate and it’s relationship to hematocrit in giant cell arteritis. Arch Ophthalmol 105: 965–967, 1987PubMedGoogle Scholar
  110. 108.
    Bottinger LE, Svedberg CA. Normal erythrocyte sedimentation rate and age. Br Med J 2: 85–87, 1967Google Scholar
  111. 109.
    Bruk MI. Articular and vascular manifestations of polymyalgia rheumatica. Ann Rheum Dis 26: 103–116, 1967PubMedGoogle Scholar
  112. 110.
    Hedges TR III, Gieger GL, Albert DM. The clinical value of negative temporal artery biopsy specimens. Arch Ophthalmol 101: 1251–1254, 1983PubMedGoogle Scholar
  113. 111.
    Eschaghian J. Cranial arteritis: a review of 79 cases. Stroke 11: 9, 1980Google Scholar
  114. 112.
    Malmvall BE, Bengtsson BA, Kaijser B, Nilsson LA, Alestig K. Serum levels of immunoglobulin and complement in giant-cell arteritis. JAMA 236: 1876–1878, 1976PubMedGoogle Scholar
  115. 113.
    Chess J, Albert DM, Bhan AK, et al. Serologic and immunopathologic findings in temporal arteritis. AJO 96: 283–289, 1983Google Scholar
  116. 114.
    Horton BT, Brown GE. Undescribed form of arteritis of the temporal vessels. Mayo Clin Proc 7: 700–701, 1932Google Scholar
  117. 115.
    Elliot PD, Baker HL, Brown AL. The superficial temporal artery angiogram. Radiology 102: 635–638, 1972Google Scholar
  118. 116.
    Alpert DM, Searl SS, Craft JL. Histologic and ultrastructural characteristics of temporal arteritis. the value of the temporal artery biopsy. Ophthalmology 89: 1111–1126, 1982Google Scholar
  119. 117.
    Kimmelstiel P, Gilmour MT, Hodges HH. Degeneration of elastic fibers in granulomatous giant cell arteritis (temporal arteritis). Arch Pathol 54: 157–168, 1952Google Scholar
  120. 118.
    Albert DM, Ruchman MC, Keltner JL. Skip lesions in temporal arteritis. Arch Ophthalmol 94: 2072–2077, 1976PubMedGoogle Scholar
  121. 119.
    Cohen DN, Smith TR. Skip areas in temporal arteritis: myth versus fact. Trans Am Acad Ophthalmol Otolaryngol 78: 772–783, 1974Google Scholar
  122. 120.
    Wadman B, Werner I. Observations on temporal arteritis. Act Med Scand 192: 377–383, 1972Google Scholar
  123. 121.
    Sorenson S, Lorenzen I. Giant-cell arteritis, temporal arteritis and polymyalgia rheumatica. A retrospective study of 63 patients. Acta Medica Scandinavica 201: 207–213, 1977Google Scholar
  124. 122.
    Allsop CJ, Gallagher PJ. Temporal artery biopsy in giant cell arteritis: a reppraisal. Am J Surg Pathol 5: 317–323, 1981PubMedGoogle Scholar
  125. 123.
    Egge K, Mitbo A, Westby R. Arteritis temporalis. Acta Ophthalmol 44: 49–56, 1966Google Scholar
  126. 124.
    Klein RG, Campbell RJ, Hunder GG, Carney JA. Skip lesions in temporal arteritis. Mayo Clin Proc 51: 504–510, 1976PubMedGoogle Scholar
  127. 125.
    Goodman BW. Temporal arteritis. Am J Med 67: 839–852, 1979PubMedGoogle Scholar
  128. 126.
    McDonnell PJ, Moore GW, Miller NR, et al. Temporal arteritis: a clinicopathologic study. Ophthalmology 93: 518–530, 1986PubMedGoogle Scholar
  129. 127.
    Allison MC, Gallagher PJ. Temporal artery biopsy and corticosteroid treatment. Ann Rheum Dis 43: 416–417, 1984PubMedGoogle Scholar
  130. 128.
    Siemssen SJ. On the occurrence of necrotising lesions in arteritis temporalis: review of the literature with a note on the potential risk of a biopsy. Br J Plastic Surgery 40: 73–82, 1987Google Scholar
  131. 129.
    Lie JT, Gordon LP, Titus JL. Juvenile temporal arteritis. biopsy study of four cases. JAMA 234: 496–499, 1975PubMedGoogle Scholar
  132. 130.
    Parker JR, Jones HG, Harkiss GD, Hazleman BL. Circulating immune complexes in polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis 40: 360–365, 1980Google Scholar
  133. 131.
    Wells KK, Folberg R, Goeken JA, Kemp JD. Temporal artery biopsies. correlation of light microsco py and immunoflurorescence microscopy. Ophthalmol 96: 1058–1064, 1989Google Scholar
  134. 132.
    Liang GC, Simkin PA, Mannik M. Immunoglobulins in temporal arteries: an immunofluorescent study. Ann Int Med 81: 19–24, 1974PubMedGoogle Scholar
  135. 133.
    Waaler E, Tonder O, Milde EJ. Immunological and histological studies of temporal arteries from patients with temporal arteritis and/or polymlyalgia rheumatica. Acta Pathol Microbiol Scand (A) 84: 55–63, 1976Google Scholar
  136. 134.
    Spencer WH, Hoyt WE A fatal case of giant-cell arteritis (temporal or cranial arteritis) with ocular involvement. Arch Ophthalmol 64: 862–867, 1960Google Scholar
  137. 135.
    Wilkse KR, Healey LA. Polymyalgia rheumatica. a manifestation of systemic giant-cell arteritis. Ann Intern Med 66: 77–86, 1967Google Scholar
  138. 136.
    Rodenhauser JH. Über pathologisch-anatomische Augenveränderungen bei generalisierter Riesenzellarteriitis. Klin Mbl Augenheilk 145: 414–429, 1964Google Scholar
  139. 137.
    MacFaul PA. Ciliary artery involvement in giant cell arteritis. Br J Ophthalmol 51: 505–512, 1967PubMedGoogle Scholar
  140. 138.
    Blumberg S, Giansiracusa DF, Docken WP, Kantrowitz FG. Recurrence of temporal arteritis. Clinical recurrence nine years after initial illness. JAMA 244: 1713–1714, 1980PubMedGoogle Scholar
  141. 139.
    Cullen JF. Temporal arteritis occurrences of ocular complications seven years after diagnosis. Br J Ophthalmol 56: 584–588, 1972PubMedGoogle Scholar
  142. 140.
    Beevers DG, Harpur JE, Turk KAD. Giant cell arteritis: the need for prolonged treatment. J Chron J Dis 26: 571–584, 1973Google Scholar
  143. 141.
    Mosher HA. The prognosis in temporal arteritis. Arch Ophthalmol 62: 641–644, 1959Google Scholar
  144. 142.
    Bengtsson BA. Eye complications in giant cell arteritis. Acta Med Scand 658: 38–43, 1982Google Scholar
  145. 143.
    Russell RWR. Giant-cell arteritis: a review of 35 cases. Q J Med 28: 471–478, 1959Google Scholar
  146. 144.
    Birkhead NC, Wagener HP, Shick RM. Treatment of temporal arteritis with adrenal corticosteroids. Results in fifty-five case in which lesion was proved at biopsy. JAMA 163: 821–827, 1957Google Scholar
  147. 145.
    Whitfield AGW, Cooke WT, Jameson-Evans P, Rudd C. Temporal arteritis and its treatment with cortisone and ACTH. Lancet I: 408–410, 1953Google Scholar
  148. 146.
    Lockshin MD. Diplopia as early sign of temporal arteritis. Arthritis Rheum 13: 419–421, 1970PubMedGoogle Scholar
  149. 147.
    Schneider HA, Weber AA, Ballen PH. The visual prognosis in temporal arteritis. Ann Ophthalmol 3: 1215–1227, 1971PubMedGoogle Scholar
  150. 148.
    Grahm E. Survival in temporal arteritis. Trans Ophthalmol Soc UK 100: 108–110, 1980Google Scholar
  151. 149.
    Rosenfeld SI, Kosmorsky GS, Klingele TG, Burder RM, Cohn EM. Treatment of temporal arteritis with ocular involvement. Am J Med 80: 143–145, 1986PubMedGoogle Scholar
  152. 150.
    Model DG. Reversal of blindness in temporal arteritis with methylprednisolone. Lancet I: 340, 1978Google Scholar
  153. 151.
    Slavin ML, Margolis AJ. Progressive anterior ischemic optic neuropathy due to giant cell arteritis despite high-dose intravenous corticosteroids. Arch Ophthalmol 106: 1167, 1988PubMedGoogle Scholar
  154. 152.
    Hunder GG, Sheps SG, Allen GL, Joyce JW. Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis. Comparison in a prospective study. Ann Int Med 82: 613–618, 1975PubMedGoogle Scholar
  155. 153.
    Doury P, Fabresse FX, Pattin S, Eulry F, Celton H, Larroque P. La place de la dapsone dans le traitement de la maladie de Horton et de la pseudopolyarthrite rhizomelique. Ann Med Interne 135: 31–35, 1984Google Scholar
  156. 154.
    Reinitz E, Aversa A. Long-term treatment of temporal arteritis with dapsone. Am J Med 85: 456–457, 1988PubMedGoogle Scholar
  157. 155.
    Graisely B, Audebert AA, Offret H, de Saint Maur PP. Evolutivite de la maladie de Horton sous corticotherapie. Nouv Presse Med 9: 2736, 1980PubMedGoogle Scholar
  158. 156.
    Green GJ, Lessell S, Loewenstein JI. Ischemic optic neuropathy in chronic papilledema. Arch Ophthalmol 98: 502–504, 1980PubMedGoogle Scholar
  159. 157.
    Orcutt JC, Page NGR, Sanders MD. Factors affecting visual loss in benign intracranial hypertension. Ophthalmology 91: 1303–1312, 1984PubMedGoogle Scholar
  160. 157a.
    Wall M, Hart W, Burde R. Visual field defects in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 96: 654–669, 1983PubMedGoogle Scholar
  161. 158.
    Jamison RR. Subretinal neovascularization and papilledema associated with pseudotumor cerebri. Am J Ophthalmol 85: 78–81, 1978PubMedGoogle Scholar
  162. 159.
    Ernest JT, Potts AM. Pathophysiology of the distal portion of the optic nerve: I. tissue pressure relationships., Am J Ophthalmol 66: 373–380, 1968PubMedGoogle Scholar
  163. 160.
    Ernest JT, Potts AM. Pathophysiology of the distal portion of the optic nerve: II vascular relationships. Am J Ophthalmol 66: 380–387, 1968PubMedGoogle Scholar
  164. 161.
    Hayreh SS. Optic disc edema in raised intracranial pressure. V. Pathogenesis. Arch Ophthalmol 95: 1553–1565, 1977PubMedGoogle Scholar
  165. 162.
    Hayreh SS. Optic disc edema in raised intracranial pressure. VI. Associated visual disturbances and their pathogenesis. Arch Ophthalmol 95: 1566–1579, 1977PubMedGoogle Scholar
  166. 163.
    Hedges TR, Zaren HA. The relationship of optic nerve tissue pressure to intracranial and systemic arterial pressure. Am J Ophthalmol 75: 90–98, 1973PubMedGoogle Scholar
  167. 164.
    Tso MOM, Hayreh SS. Optic disc edema in raised intracranial pressure. III. A pathologic study of experimental papilledema. Arch Ophthalmol 95: 1448–1457, 1977PubMedGoogle Scholar
  168. 165.
    Tso MOM, Hayreh SS. Optic disc edema in raised intracranial pressure. IV. Axoplasmic transport in experimental papilledema. Arch Ophthalmol 95: 1458–1462, 1977PubMedGoogle Scholar
  169. 166.
    Sadun AA, Currie JN, Lessell S. Transient visual obscurations with elevated optic discs. Ann Neurol 16: 489–494, 1984PubMedGoogle Scholar
  170. 167.
    Li JC, Magargal LE, Carabasi A. Dynamic amaurosis fugax secondary to compression of vertebral artery. Ann Ophthalmol 20: 219–224, 1988PubMedGoogle Scholar
  171. 168.
    Nikoskelainen EK, Savontaus ML, Wanne OP, Katila MJ, Nummelin KU. Leber’s hereditary optic neuroretinopathy, a maternaly inherited disease. A genealogie study in four pedigrees. Arch Ophthalmol 105: 665–671, 1987PubMedGoogle Scholar
  172. 169.
    Novotny EJ, Gurparkash S, Wallace DC, et al. Leber’s disease and dystonia: a mitochondrial disease. Neurology 36: 1053–1060, 1986PubMedGoogle Scholar
  173. 170.
    Parker WD, Oley CA, Parks JK. A defect in mitochondrial electron-transport activity (NADH-coen-zyme Q oxidoreductase) in Leber’s hereditary optic neuropathy. NEJM 320: 1331–1333, 1989PubMedGoogle Scholar
  174. 171.
    Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy. Science 242: 1427–1430, 1988PubMedGoogle Scholar
  175. 172.
    Pages M, Pages AM. Leber’s disease with spastic paraplegia and peripheral neuropathy: case report with nerve biopsy study. Eur Neurol 22: 181–185, 1983PubMedGoogle Scholar
  176. 173.
    Smith JL, Hoyt WF, Susac J. Ocular fundus in acute Leber optic neuropathy. Arch Ophthalmol 90: 349–354, 1973PubMedGoogle Scholar
  177. 174.
    Nikoskelainen E, Hoyt WF, Nummelin K. Ophthalmoscopic findings in Leber’s hereditary optic neuropathy. I. Fundus findings in asymptomatic family members. Arch Ophthalmol 100: 1597–1602, 1982PubMedGoogle Scholar
  178. 175.
    Nikoskelainen E, Sogg RL, Rosenthal AR, et al. The early phase in Leber hereditary optic atrophy. Arch Ophthalmol 95: 969–978, 1977PubMedGoogle Scholar
  179. 176.
    Carroll WM, Mastaglia FL. Leber’s optic neuropathy: a clinical and visual evoked potential study of affected and asymptomatic members of a six generation family. Brain 102: 559–580, 1979PubMedGoogle Scholar
  180. 177.
    Nikoskelainen E, Hoyt WF, Nummelin K, Schatz H. Fundus findings in Leber’s herediatry optic neuropathy. III. Fluorescein angiographic studies. Arch Ophthamol 102: 981–989, 1984Google Scholar
  181. 178.
    Lessell S, Gise MD, Krohel GB. Bilateral optic neuropathy with remission in young men. Variation on a theme by Leber? Arch Neurol 40: 2–6, 1983PubMedGoogle Scholar
  182. 179.
    Brunette JR, Bernier RG. Diagnostic et prognostic de la maladie de Leber: incidence de la recuperation totale spontanee. Union Med Canada 99: 643–652, 1970Google Scholar
  183. 180.
    Holt IJ, Miller DH, Harding AE. Genetic heterogeneity and mitochondrial DNA heteroplasmy in Leber’s hereditary optic neuropathy. J Med Genetics 26: 739–743, 1989Google Scholar
  184. 181.
    Singer KO. Ueber Sehstoerungen nach Blutverlust. Beitr Augenheilkd 6: 1–30, 1904Google Scholar
  185. 182.
    Pears MA and Pickering GW: Changes in the fundus oculi after hemorrhage. Q J Med 29: 153–178, 1960.PubMedGoogle Scholar
  186. 183.
    Prescencia AC, Hernandez AM, and Guia ED: Amaurosis and blood loss. Ophthalmologica 191: 119–121, 1985.Google Scholar
  187. 184.
    Chisholm IA. Optic neuropathy of recurrent blood loss. Br J Ophthalmol 53: 289–295, 1969PubMedGoogle Scholar
  188. 185.
    Castaigne P, Brunet P, Derovesne C, et al. Atrophie optique post-hemorragique. Nouv Presse Med 5: 1631–1633, 1976PubMedGoogle Scholar
  189. 186.
    Levatin P. Atrophy of the optic nerve following hemorrhage. Arch Ophthalmol 37: 18–24, 1947Google Scholar
  190. 187.
    Klewin KM, Appen RE, Kaufman PL. Amaurosis and blood loss. AJO 86: 669–672, 1978Google Scholar
  191. 188.
    Drance SM, Morgan RW, Sweeney VP. Shock-induced optic neuropathy. A cause of nonprogressive glaucoma. NEJM 288: 392–395, 1973PubMedGoogle Scholar
  192. 189.
    Sweeney PJ, Breuer AC, Seihorst JB, et al. Ischemic optic neuropathy: a complication of cardiopulmonary bypass surgery. Neurology 32: 560–562, 1982PubMedGoogle Scholar
  193. 190.
    Hayreh SS. Posthemorrhagic amaurosis. Invest Ophthalmol Vis Sci 28: 321, 1987Google Scholar
  194. 191.
    Jampol LM, Board RJ, Maumenee AE. Systemic hypotension and glaucomatous changes. Am J Ophthalmol 85: 154–159, 1978PubMedGoogle Scholar
  195. 192.
    Rizzo JF, Lesseil S. Posterior optic neuropathy during general surgery. AJO 103: 808–811, 1987Google Scholar
  196. 193.
    Drance SM. The visual field of low tension glaucoma and shock-induced optic neuropathy. Arch Ophthalmol 95: 1359–1361, 1977PubMedGoogle Scholar
  197. 194.
    Peck V, Lieberman A, Pinto R, Culliford A. Pituitary apoplexy following open heart surgery. N Y State J Med 641-643, 1980Google Scholar
  198. 195.
    Slavin ML, Budabin M. Pituitary apoplexy associated with cardiac surgery. Am J Ophthalmol 98: 291–326, 1984PubMedGoogle Scholar
  199. 196.
    Drance SM, Sweeney VP, Morgan RW, Feldman F. Studies of factors involved in the production of low tension glaucoma. Arch Ophthalmol 89: 457–465, 1973PubMedGoogle Scholar
  200. 197.
    Graefe A von. Über die Iridectomie bei Glaucoma und über den glaucomatosen Progress. Albrecht von Graefes Arch Ophthal 3: 456–465, 1857Google Scholar
  201. 198.
    Schnabel I. Das glaucomatose Sehnervenleiden. Arch Augenheilk 24: 273–292, 1892Google Scholar
  202. 199.
    Levene RZ. Low tension glaucoma: A critical review and new material. Surv Ophthalmol 24: 621–664, 1980PubMedGoogle Scholar
  203. 200.
    Caprioli J, Spaeth GL. Comparison of visual field defects in the low-tension glaucomas with those in the high-tension glaucomas. Am J Ophthalmol 97: 730–737, 1984PubMedGoogle Scholar
  204. 201.
    Drance SM, Douglas GR, Airaksinen, et al. Diffuse visual field loss in chronic open-angle and low-tension glaucoma. Am J Ophthalmol 104: 577–580, 1987PubMedGoogle Scholar
  205. 202.
    Caprioli J, Spaeth GL. Comparison of optic nerve head in high-and low-tension glaucoma. Arch Ophthalmol 103: 1145–1149, 1985PubMedGoogle Scholar
  206. 203.
    Spaeth GL. Fluorescein angiography: Its contributions toward understanding the mechanisms of visual loss in glaucoma. Trans Am Ophthalmol Soc 73: 491–553, 1975PubMedGoogle Scholar
  207. 204.
    Fishbein SL, Schwartz B. Optic disc in glaucoma: topography and extent of fluorescein filling defects. Arch Ophthalmol 95: 1975-1979Google Scholar
  208. 205.
    Nanba K, Schwartz B. Nerve fiber layer and optic disc fluorescein defects in glaucoma and ocular hypertension. Ophthalmology 95: 1227–1233, 1988PubMedGoogle Scholar
  209. 206.
    Lewis RA, Hayreh SS, Phelps CD. Optic disk and visual field correlations in primary open-angle and low-tension glaucoma. Am J Ophthalmol 96: 148–152, 1983PubMedGoogle Scholar
  210. 207.
    Hayreh SS. Pathogenesis of visual field defects. Role of the ciliary circulation. Br J Ophthalmol 54: 289–311, 1970PubMedGoogle Scholar
  211. 208.
    Salmon ML, Gay AJ. Ophthalmodynamometry. In Gay AJ, Burde RM (ed). Clinical concepts in neuroophthalmology. Int Ophthalmol Clin 7: 745–764, 1967PubMedGoogle Scholar
  212. 209.
    Phelps CD, Corbett JJ. Migraine and low-tension glaucoma. A case-control study. Inves Ophthalmol Vis Sci 26: 1105–1108, 1985Google Scholar
  213. 210.
    Aulhorn E, Tanzil M. Comparison of visual field defects in glaucoma and in acute anterior ischemic optic neuropathy. Docum Ophthal Proc Series 19: 73–79, 1979Google Scholar
  214. 211.
    Hayreh SS. Pathogenesis of optic nerve head changes in glaucoma. Seminars Ophthal 1: 1–13, 1986Google Scholar
  215. 212.
    Quigley HA, Addicks EM, Green WR, et al. Optic nerve damage in human glaucoma II. The site of injury and susceptibility to damage. Arch Ophthalmol 99: 635–649, 1981PubMedGoogle Scholar
  216. 213.
    Quigley HA, Hohman RM, Sanchez R, et al. Optic nerve head blood flow in chronic experimental glaucoma. Arch Ophthal 103: 956–962, 1985PubMedGoogle Scholar
  217. 214.
    Cristini G. Common pathological basis of the nervous ocular symptoms in chronic glaucoma. Br J Ophthalmol 35: 11–20, 1951PubMedGoogle Scholar
  218. 215.
    Carter CJ, Brooks DE, Doyle DL, Drance SM. Investigations into a vascular etiology for low-tension glaucoma. Ophthalmol 97: 49–55, 1990Google Scholar
  219. 216.
    Quigley HA, Addicks EM, Green WR. Optic nerve damage in human glaucoma III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophthalmol 100: 135–146, 1982PubMedGoogle Scholar
  220. 217.
    Brownstein S, Font RL, Zimmerman LE, Murphy SB. Nonglautomaous cavernous degeneration of the optic nerve. report of two cases. Arch Ophthalmol 98: 354–358, 1980PubMedGoogle Scholar
  221. 218.
    Giarelli L, Melato M, Campos E. Fourteen cases of cavernous degeneration of the optic nerve. Ophthalmologica 174: 316–321, 1977PubMedGoogle Scholar
  222. 219.
    Hilton GF, Hoyt WF. An arteriosclerotic chiasmal syndrome. Bitemporal hemianopia associated with fusiform dilatation of the anterior cerebral arteries. JAMA 196: 1018–1020Google Scholar
  223. 220.
    Portney GL, Roth AM: Optic cupping caused by an intracranial aneurysm. Am J Ophthal 84: 98–103, 1977PubMedGoogle Scholar
  224. 221.
    Kupersmith MJ, Krohn D. Cupping of the optic disc with compressive lesions of the anterior visual pathway. Ann Ophthalmol 16: 948–952, 1984PubMedGoogle Scholar
  225. 222.
    Cartwright MJ, Anderson DR. Correlation of asymmetric damage with asymmetric intraocular pressure in normal-tension glaucoma (low-tension glaucoma). Arch Ophthalmol 106: 898–900, 1988PubMedGoogle Scholar
  226. 223.
    Begg IS, Drance SM, Goldman H. Fluorescein angiography in the evaluation of focal circulatory ischaemia of the optic nerve head in relation to the arcuate scotoma in glaucoma. Cand J Ophthalmol 7: 68–74, 1972Google Scholar
  227. 224.
    Chumbley LC, Brubaker RF. Low tension glaucoma. Am J Ophthalmol 81: 761–767, 1976PubMedGoogle Scholar
  228. 225.
    Drance SM. Some factors in the production of low tension glaucoma. Br J Ophthalmol 56: 229–242, 1972PubMedGoogle Scholar
  229. 226.
    O’Brien IAD, O’Hare JP, Lewin IG, Corrall RJM. Papilledema in diabetes: an ischaemic optic mononeuropathy. Lancet 1: 267–269, 1984PubMedGoogle Scholar
  230. 227.
    Barjon P, Lestradet H, Labauge R. Atrophie optique primitive et surdite neurogene dans le diabete junvenile (a propos de trois observations). Presse Med 72: 983–985, 1964PubMedGoogle Scholar
  231. 228.
    Marquardt JL, Loriaux L. Diabetes mellitus and optic atrophy: with associated findings of diabetes insipidus and neurosensory hearing loss in two siblings. Arch Intern Med 134: 32–37, 1974PubMedGoogle Scholar
  232. 229.
    Lessell S, Rosman NP. Juvenile diabetes mellitus and optic atrophy. Arch Neurol 34: 759–765, 1977PubMedGoogle Scholar
  233. 230.
    Lyle TK, Wybar K. Retinal vasculitis. BJO 45: 778–788, 1961Google Scholar
  234. 231.
    Lonn LI, Hoyt WF. Papillophlebitis. A cause of protracted yet benign optic disc edema. Eye Ear Nose Throat Mon. 45: 62–68, 1966PubMedGoogle Scholar
  235. 232.
    Hart CD, Sanders MD, Miller SJH. Benign retinal vasculitis. clinical and fluorscein angiographic study. Br J Ophthalmol 55: 721–723, 1971PubMedGoogle Scholar
  236. 233.
    Ellenberger C, Messner KH. Papillophlebitis: Benign retinopathy resembling papilledema or papillitis. Ann Neurol 3: 438–440, 1978PubMedGoogle Scholar
  237. 234.
    Miller N. The big blind spot syndrome: unilateral optic disc edema without visual loss or increased intracranial pressure. In: Smith JL (ed) Neuro-oph-thalmology Update. New York, Masson, pp 163–169, 1977Google Scholar
  238. 235.
    Hayreh SS. Central retinal vein occlusion. In: The eye and systemic disease. CV Mosby, St Louis, 1980, pp 223–275Google Scholar
  239. 236.
    Kirkham TH, Sanders MD, Sapp GA. Unilateral papilledema in benign intracranial hypertension. Cand J Ophthal 8: 533–538, 1973Google Scholar
  240. 237.
    Fletcher WA, Imes RK, Goodman D, Hoyt WF. Acute idiopathic blind spot enlargement. A big blind spot syndrome without optic disc edema. Arch Ophthalmol 106: 44–49, 1988PubMedGoogle Scholar
  241. 238.
    Kimmel AS, Folk JC, Thompson HS, Strnad LS. The multiple evanescent white-dot syndrome with acute blind spot enlargement. Am J Ophthal 107: 425–428, 1989PubMedGoogle Scholar
  242. 239.
    D’Amato RJ, Miller NR, Fine SL, Enger C, Quinlan P, Elman MJ. Papillophlebitis and central retinal vein occlusion: a comparison of prognosis. Invest Ophthalmol Vis Sci 28: 43, 1987Google Scholar
  243. 240.
    Coats G. Further cases of thrombosis of the central vein. Ophthalmol Rec 16: 516–561, 1906Google Scholar
  244. 241.
    Cogan DG. Retinal and papillary vasculitis. In: Cant JS (ed) The William Mackenzie Centenary Symposium on the Ocular Circulation in Health and Disease. St. Louis, C.V. Mosby, 1969, pp 249–270Google Scholar
  245. 242.
    Appen RE, de Venecia G, Ferwerda J. Optic disk vasculitis. Am. J Ophthalmol 90: 352–359, 1980PubMedGoogle Scholar
  246. 243.
    Hayreh SS. Optic disc vasculitis. Br J Ophthalmol 56: 652–670, 1972PubMedGoogle Scholar
  247. 244.
    Shimo-Oku M, Miyazaki S. Acute anterior and posterior ischemic optic neuropathy. Jap J Ophthalmol 28: 159–170, 1984Google Scholar
  248. 245.
    Isayama Y, Takahashi T. Posterior ischemic optic neuropathy. II Histopathology of the idiopathic form. Ophthalmolgica 187: 8–18, 1983Google Scholar
  249. 246.
    Isayama Y, Takahashi T, Inoue M, Jimura T. Posterior ischemic optic neuropathy. III Clinical diagnosis. Ophthalmologica 187: 141–147, 1983PubMedGoogle Scholar
  250. 247.
    Doron Y, Behar A. Pathology of the optic nerves. I Histopathological changes in the intracranial portions, associated with arteriolsclerotic and hypertensive cardiovascular diseases and with liver parenchymal damage. Acta Neuropathol 10: 273–278, 1968PubMedGoogle Scholar
  251. 248.
    Hayreh SS. Posterior ischemic optic neuropathy. Ophthalmologica 182: 29–41, 1981PubMedGoogle Scholar
  252. 249.
    Bogousslavsky J, Regli F, Zografos L, and Uske A: Optico-cerebral syndrome: Simultaneous hemodynamic infarction of optic nerve and brain. Neurology 37: 263–268, 1987PubMedGoogle Scholar
  253. 250.
    Kramer S. The hazards of therapeutic irradiation of the central nervous system. Clin Neurosurg 15: 301–318, 1968PubMedGoogle Scholar
  254. 251.
    Chan RC, Shukovsky LJ. Effects of radiation on the eye. Radiology 120: 673–675, 1976PubMedGoogle Scholar
  255. 252.
    Price RA, Jamieson PA. The central nervous system in childhood leukemia. II. Subacute leukoencephalopathy. Cancer 35: 306–318, 1975PubMedGoogle Scholar
  256. 253.
    Painter MJ, Chutorian AM, Hilal SK. Cerebrovasculopathy following irradiation in childhood. Neurology 25: 189–194, 1975PubMedGoogle Scholar
  257. 254.
    Similia S, Heikkinen E, Blanco G, Taskinen PJ, Kouvalainen K, Lanning M, Saukkonen AL. Brain damage in relation to irradiation and chemotherapy of central nervous system. Lancet 1: 1000–1001, 1977Google Scholar
  258. 255.
    Kramer S, Lee KF. Complications of radiation therapy: the central nervous system. Semin Roentgenol 9: 75–83, 1974PubMedGoogle Scholar
  259. 256.
    Merchut MP, Haberland C, Naheedy MH, Rubino FA. Long survival of primary cerebral lymphoma with progressive radiation necrosis. Neurology 35: 552–556, 1985PubMedGoogle Scholar
  260. 257.
    Buys NS, Kearns TC. Irradiation damage to the chiasm. Am J Ophthalmol 44: 483–486, 1957PubMedGoogle Scholar
  261. 258.
    Forrest APM. Pituitary radon implant for advanced cancer. Lancet i: 399–401, 1956Google Scholar
  262. 259.
    Peck FC, McGovern ER. Radiation of the brain in acromegaly. J Neurosurg 15: 536–542, 1966Google Scholar
  263. 260.
    Rider WD. Radiation damage to the brain — a new syndrome. J Can Assoc Radiol 14: 67–69, 1963PubMedGoogle Scholar
  264. 261.
    Stallard HB. Radiant energy as (A) a pathogenic (B) a therapeutic agent in ophthalmic disorders. Br J Ophthalmol 70 (mono suppl VI): 67-79, 133Google Scholar
  265. 262.
    Moore RF. Presidential address. Trans Ophthalmolo Soc UK 55: 3–26, 1935Google Scholar
  266. 263.
    Chee PHY. Radiation retinopathy. Am J Ophthal 66: 860–865, 1968PubMedGoogle Scholar
  267. 264.
    Shukorsky LJ, Fletcher LJ. Effect of irradiation on the eye. Radiology 120: 673–675, 1976Google Scholar
  268. 265.
    Howard GM. Ocular effects of radiation and photocoagulation. A study of 100 globes with retinoblastoma, some of which were treated prior to enucleation. Arch Ophthalmol 76: 7–10, 1966PubMedGoogle Scholar
  269. 266.
    Egbert PR, Fajardo LF, Donaldson SS, Moazed K. Posterior ocular abnormalities after irradiation for retinoblastoma: a histopathological study. Br J Ophthalmol 64: 660–665, 1980PubMedGoogle Scholar
  270. 267.
    Char DH, Lonn LI, Margolis IW. Complications of cobalt plaque therapy of choroidal melanoma. AJO 84: 536–547, 1977Google Scholar
  271. 268.
    Bedford MA, Bedotto C, MacFaul PA. Radiation retinopathy after the application of a cobalt plaque. Report of three cases. Br J Ophthalmol 54: 505–509, 1970PubMedGoogle Scholar
  272. 269.
    Bagan SM, Hollenhorst RW. Radiation retinopathy after irradiation of intracranial lesions. AJO 88: 694–697, 1979Google Scholar
  273. 270.
    Rush SC, Kupersmith MJ, Lerch I, et al. Neuroophthalmological assessment of vision before and after radiation therapy alone for pituitary macroadenomas. J Neurosurg 72: 594–599, 1990PubMedGoogle Scholar
  274. 271.
    Hayreh SS. Postradiation retinopathy: a fluorescein fundus angiographic study. Br J Ophthalmol 54: 765–774, 1970Google Scholar
  275. 272.
    Brown GC, Shields JA, Sanborn G, Augsberger JJ, Savino PJ, Schatz NJ. Radiation retinopathy. Ophthalmology 89: 1494–1501, 1982PubMedGoogle Scholar
  276. 273.
    Noble K, Kupersmith MJ. Retinal vascular remod elling in radiation retinopathy. Br J Ophthalmol 68: 475–478, 1984PubMedGoogle Scholar
  277. 274.
    Ross H, Rosenberg S, Friedman A. Delayed radiation necrosis of the optic nerve. Am J Ophthalmol 76: 683–686, 1973PubMedGoogle Scholar
  278. 275.
    Singh J, Vashist S. Postirradiation optic neuropathy in antral carcinoma. J Clin Neuro-ophthalmol 4: 103–104, 1984Google Scholar
  279. 276.
    Hashimoto N, Handa H, Yamashita J, et al. Longterm follow-up of large or invasive pituitary adenomas. Surg Neurol 25: 49–54, 1986PubMedGoogle Scholar
  280. 277.
    Crompton MR, Layton DD. Delayed radionecrosis of the brain following therapeutic X-radiation of the pituitary. Brain 84: 84–101, 1961Google Scholar
  281. 278.
    Schatz N, Lichtenstein S, Corbett JJ. Delayed radiation necrosis of the optic nerves and chiasm. In: Neuro-ophthalmology VIII, Glaser JS, Smith JL (eds). C.V. Mosby, St. Louis, 1975, pp 131–139Google Scholar
  282. 279.
    Kupersmith MJ, Warren FA, Newall J, Ransohoff J. Irradiation of meningiomas of the intracranial anterior visual pathway. Ann Neurol 21: 131–137, 1987PubMedGoogle Scholar
  283. 280.
    Harris JR, Levene MB. Visual complications following irradiation for pituitary adenomas and craniopharyngiomas. Ther Radiol 120: 167–171, 1976Google Scholar
  284. 281.
    McDonald LW, Hayes TL. The role of capillaries in the pathognesis of delayed radionecrosis of brain. Am J Pathology 50: 745–764, 1967Google Scholar
  285. 282.
    Eyster EF, Nielsen SL, Sheline GE, et al. Cerebral radiation necrosis simulating a brain tumor. J Neurosurg 39: 267–271, 1974Google Scholar
  286. 283.
    Wright TL, Bresnan MJ. Radiation-induced cerebrovascular disease in children. Neurology 26: 540–543, 1976PubMedGoogle Scholar
  287. 284.
    Hilal SK, Solomon GE, Gold AP, et al. Primary cerebral arterial occlusive disease in children. Radiology 99: 87–94, 1971PubMedGoogle Scholar
  288. 285.
    Lee KF, Hodges PJ. Intracranial ischaemic lesions. Rad Clin North Am 5: 363–393, 1973Google Scholar
  289. 286.
    Beyer RA, Paden P, Sobel DF, Flynn FG. Moyamoya pattern of vascular occlusion after radiotherapy for glioma of the optic chiasm. Neurology 36: 1173–1178, 1986PubMedGoogle Scholar
  290. 287.
    McCready RA, Hyde GL, Bivins BA, et al. Radiation-induced arterial injuries. Surgery 93: 306–312,1973Google Scholar
  291. 288.
    Benson EP. Radiation injury to large arteries: 3 further examples with prolonged asymptomatic intervals. Radiology 106: 195–197, 1973PubMedGoogle Scholar
  292. 289.
    Silverberg GD, Britt RH, Goffinet DR. Radiation induced carotid artery disease. Cancer 41: 130–137, 1978PubMedGoogle Scholar
  293. 290.
    Butler MJ, Lane RHS, Webster JHH. Irradiation injury to large arteries. Br J Surg 93: 341–343, 1980Google Scholar
  294. 291.
    St Louis EL, McLoughlin MJ, Wortzman G. Chronic damage to medium and large arteries following irradiation. J Can Assoc Radiol 25: 94–104, 1974Google Scholar
  295. 292.
    Conomy JP, Kellermeyer R. Delayed cerebrovascular consequences of therapeutic radiation: A clinicopathologic study of a stroke association with radiation-related carotid arteriography. Cancer 36: 1702–1708, 1975PubMedGoogle Scholar
  296. 293.
    Elerding SC, Fernandez RN, Grotta JC, Lindberg RD, Causay LC, McMurtrey MJ. Carotid artery disease following external cervical irradiation. Ann Surg 194: 609–615, 1981PubMedGoogle Scholar
  297. 294.
    Murros KE, Toole JF. The effect of radiation on carotid arteries. A review article. Arch Neurol 46: 449–455, 1989PubMedGoogle Scholar
  298. 295.
    Werner MH, Burger PC, Heinz ER, Friedman AH, Halperin EC, Schold SC. Intracranial atherosclerosis following radiotherapy. Neurology 38: 1158–1160, 1988PubMedGoogle Scholar
  299. 296.
    Waltz TA, Brownell B. Sarcoma: a possible late result of effective radiation therapy for pituitary adenoma: report of two case. J Neurosurg 24: 901–907, 1966PubMedGoogle Scholar
  300. 297.
    Amine ARC, Sugar O. Suprasellar osteogenic sarcoma following radiation for pituitary adenoma. J Neurosurg 44: 88–91, 1976PubMedGoogle Scholar
  301. 298.
    Iacono P, Apuzzo MLJ, Davis RL. Multiple meningiomas following radiation for medulloblastomas: case report. J Neurosurg 55: 282–286, 1981PubMedGoogle Scholar
  302. 299.
    Ushio Y, Arita N, Yoshimine T, et al. Glioblastoma after radiotherapy for craniopharyngioma: case report. Neurosurgery 21: 33–38, 1987PubMedGoogle Scholar
  303. 300.
    Marus G, Levin V, Rutherford S. Malignant glioma following radiotherapy for unrelated primary tumors. Cancer 58: 886–894, 1986PubMedGoogle Scholar
  304. 301.
    Liwnciz BH, Berger TS, Liwnciz RG, et al. Radiation-associated gliomas: a report of four case and analysis of postradiation tumors of the central nervous system. Neurosurgery 17: 436–445, 1985Google Scholar
  305. 302.
    Hufnagel TJ, Kim JH, Lesser R, et al. Malignant glioma of the optic chiasm eight years after radiotherapy for prolactinoma. Arch Ophthalmol 106: 1701–1705, 1988PubMedGoogle Scholar
  306. 303.
    Nakissa N, Rubin P, Strohl R, Keys H. Ocular and orbital complications following radiation therapy of paranasal sinus malignancies. Cancer 51: 980–986, 1983PubMedGoogle Scholar
  307. 304.
    Stephens LC, Schultheiss TE, Peters LJ, Ang KK, Gray KN. Acute radiation injury of ocular adnexa. Arch Ophthalmol 106: 389–391, 1988PubMedGoogle Scholar
  308. 305.
    Gass JDM. A fluorescein angiographic study of macular dysfunction secondary to retinal vascular disease. Arch Ophthalmol 80: 606–617, 1968PubMedGoogle Scholar
  309. 306.
    Chaudhuri PR, Austin DJ, Rosenthal AR. Treatment of radiation retinopathy. Br J Ophthalmol 65: 623–625, 1981PubMedGoogle Scholar
  310. 307.
    Lampert PW, Tom MI, Rider WD. Disseminated demyelination of the brain following Co60 (gamma) radiation. Arch Pathol 68: 322–330, 1959PubMedGoogle Scholar
  311. 308.
    Guy J, Schatz NJ. Hyperbaric oxygen in the treatment of radiation-induced neuropathy. Ophthalmology 93: 1083–1088, 1986PubMedGoogle Scholar
  312. 309.
    Roden D, Bosley TM, Fowble B, et al. Delayed radiation injury to the retrobulbar optic nerves and chiasm: clinical syndrome and treatment with hyperbaric oxygen and corticosteroids. Ophthalmology 97: 346–351, 1990PubMedGoogle Scholar
  313. 310.
    Tharp B, Heyman A, Pfeiffer JB, et al. Cerebral ischaemia. Arch Neurol 12: 142–146, 1968Google Scholar
  314. 311.
    Nardelli E, Fiaschi A, Ferrari G. Delayed cerebrovascular consequences of radiation to the neck. Arch Neurol 35: 538–540, 1978PubMedGoogle Scholar
  315. 312.
    Loftus CM, Biller J, Hart MN, Cornell SH, Hiratzka LF. Management of radiation-induced accelerated carotid atherosclerosis. Arch Neurol 44: 711–714, 1987PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • Mark J. Kupersmith
    • 1
  1. 1.Director of Neuro-ophthalmology New York Eye and Ear InfirmaryNew York University Medical CenterNew YorkUSA

Personalised recommendations